The future of antibody therapy in chronic lymphocytic leukemia

Taylor and Francis Group, Expert Opinion on Emerging Drugs, 3(26), p. 323-336, 2021

Journal article published in 2021 by Jennifer L. Crombie

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by